🇺🇸 FDA
Patent

US 11433053

LSD1 inhibitor and preparation method and application thereof

granted A61KA61K31/135A61K31/165

Quick answer

US patent 11433053 (LSD1 inhibitor and preparation method and application thereof) held by Medshine Discovery Inc. expires Mon Sep 01 2042 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
Medshine Discovery Inc.
Grant date
Tue Sep 06 2022 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Sep 01 2042 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
30
CPC classes
A61K, A61K31/135, A61K31/165, A61K31/277, A61K31/40